Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04128709 · ClinicalTrials.gov registry record · NA

Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use

A NA study of Urinary Bladder, Neurogenic, sponsored by Christopher Cooper.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04128709 is a NA study of Urinary Bladder, Neurogenic that is actively recruiting participants, run by Christopher Cooper. The registered enrollment target is 50 participants, below the 64-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04128709, a NA study of Urinary Bladder, Neurogenic, is actively recruiting participants, sponsored by Christopher Cooper.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate compared to the gold standard in clinic urodynamics. This study will assess the patients and care givers ability and experience using the device in a home setting.

Interventions

  • DEVICE Urodynamics Testing

Study Locations (1)

Iowa

  • University of Iowa Hospital and Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-11-19
Est. Completion 2026-12
Phase NA

Sponsor

Christopher Cooper

1 total trials

What the Registry Record Tells You About NCT04128709

The ClinicalTrials.gov registry entry for NCT04128709 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 64-participant average among 7 other Urinary Bladder, Neurogenic trials with a reported enrollment target (22% lower). The listed sponsor is Christopher Cooper, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Bladder, Neurogenic appearing as the primary indexed condition, and to 1 intervention - of which Urodynamics Testing is the first listed.

NCT04128709 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT04128709 about?

NCT04128709 is a clinical study titled "Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use". The investigators have developed a novel pressure monitoring device that hooks to standard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate compared to the gold standard in clini...

What is the current status of trial NCT04128709?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2019-11-19. Estimated completion is 2026-12.

What conditions does trial NCT04128709 study?

This clinical trial studies the following conditions: Urinary Bladder, Neurogenic.

What interventions are being tested in trial NCT04128709?

The interventions under investigation include: Urodynamics Testing (DEVICE).

Who is sponsoring clinical trial NCT04128709?

This trial is sponsored by Christopher Cooper, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04128709 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Bladder, Neurogenic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.